May 1, 2018 (Vol. 38, No. 9)

Roche

The cobas m511 analyzer, featuring patented Bloodhound® technology, is designed to address the challenges of hematology testing by combining a cell counter, slide maker and stainer, and a digital morphology analyzer into one integrated solution. Now, laboratories can report the complete blood count (CBC), WBC differential, and reticulocyte results, and prepare, stain, and analyze blood smears for abnormal results through a single, integrated process. The cobas m 511 analyzer provides additional opportunities to improve the sensitivity and consistency of results by identifying, counting and categorizing WBCs, RBC, and platelets, and then presenting the digital images of all these cell types. This enables medical technologists to concentrate their time on classifying abnormal cells within patient samples. Additional benefits of this automation and digitalization include reducing the need for resource-intensive microscope reviews and sample handling, easy collaboration for challenging cases through remote connectivity and delivering quicker results, which ultimately aid patient diagnoses.

Previous articleConsortium Identifies 44 Variants as Risk Factors for Major Depression
Next articleFour Tips for Identifying Microbes in Your Facility